Atherosclerosis
Volume 205, Issue 2 , Pages 331-341 , August 2009

Hypertension and cerebrovascular damage

  • Franco Veglio

      Affiliations

    • Hypertension Unit, University of Turin, Italy
    • Corresponding Author InformationCorresponding author at: Hypertension Unit, S.Giovanni Battista Hospital, University of Turin, c.so Bramante 88/90, 10126, Turin, Italy. Tel.: +39 011 6336959.
    • ,
  • Cristina Paglieri

      Affiliations

    • Hypertension Unit, University of Turin, Italy
    • Corresponding Author InformationCorresponding author at: Hypertension Unit, S.Giovanni Battista Hospital, University of Turin, c.so Bramante 88/90, 10126, Turin, Italy. Tel: +39 011 6336959.
    • ,
  • Franco Rabbia

      Affiliations

    • Hypertension Unit, University of Turin, Italy
    • ,
  • Daniela Bisbocci

      Affiliations

    • Hypertension Unit, University of Turin, Italy
    • ,
  • Mauro Bergui

      Affiliations

    • Neuroradiology Division, University of Turin, Italy
    • ,
  • Paolo Cerrato

      Affiliations

    • Neurology Division, University of Turin, Italy

Received 10 May 2008 ,Revised 16 September 2008 ,Accepted 14 October 2008.

References 

  1. Aronow WS, Frishman WH. Treatment of hypertension and prevention of ischemic stroke. Curr Cardiol Rep. 2004;6(2):124–129
  2. Van der Flier W, van Straaten E, Barkhof F, et al., on behalf of the LADIS Study Group. Small vessel disease and general cognitive function in non-disabled elderly: the LADIS study. Stroke 2005; 36:2116–20.
  3. Forette F, Seux ML, Staessen J, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351
  4. Forette F, et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med. 2002;162:2046–2052
  5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
  6. Ferri CP, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117
  7. Beaglehole R, Irwin A, Prentice T. The World Health Report 2003-Shaping the future. Geneva, Switzerland: World Health Organization; 2003;
  8. Cerrato P, Grasso M, Imperiale D, et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis. 2004;18(2):154–159
  9. Staessen JA, Richard T, Birkenhager WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension. 2007;49:389–400
  10. Realdi A, Mascagna V, Ciccariello L, et al. Impaired cerebral vasoreactivity in hypertensives: an early marker of vascular dementia?. J Hypertens. 2003;21(Suppl 4):S166
  11. Schwartz RB. Hyperperfusione encephalopathies: hypertensive encephalopathy and related conditions. The Neurologist. 2002;vol. B(1):22–34
  12. Oliveira-Filho J, Koroshetz WJ. Magnetic resonance imaging in acute stroke: clinical perspective. Top Magn Reson Imaging. 2000;11(5):246–258
  13. Bergui M, Bradac GB. DWI as a marker for focal cerebral ischaemia. Lancet Neurol. 2006;5(6):470–471
  14. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hyertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27:144–147
  15. Rosenblum WI. The importance of fibrinoid necrosis as the cause of cerebral hemorrhage in hypertension. Commentary. J Neuropathol Exp Neurol. 1993;52:11–13
  16. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic oedema in a patient with eclampsia. Stroke. 1997;28(5):1082–1085
  17. Bakker RC, Verburgh CA, van Buchem MA, Paul LC. Hypertension, cerebral oedema and fundoscopy. Nephrol Dial Transplant. 2003;18(11):2424–2427
  18. Neuwelt EA. Mechanism of disease: the blood–brain barrier. Neurosurgery. 2004;54:131–142
  19. Coutts SB, Hill MD, Hu WY. Hyperperfusion syndrome. Neurosurgery. 2003;53:1053–1060
  20. Kumai Y, Toyoda K, Fujii K, Ibayashi S. Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res. 2002;25(5):797–800
  21. Port JD, Beauchamp NJ. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics. 1998;18:353–367
  22. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol. 2002;23(6):1038–1048
  23. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41
  24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809
  25. Moossy J. Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke. 1993;24(Suppl):122–123
  26. Rovira A, Grive E, Rovira A, Alvarez-Sabin J. Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol. 2005;15(March (3)):416–426
  27. Rosenblum WI. Miliary aneurisms and “fibrinoid” degeneration of cerebral blood vessels. Hum Pathol. 1997;8:133–139
  28. Van Swieten JC, Van Den Hout JH, Van ketel BA, et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991;114:761–774
  29. Van Swieten JC, Geyskes GG, Derix MM, et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991;30:825–830
  30. Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis. Stroke. 1993;24:652–656
  31. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertesive cerebral small-vessel disease: an autopsy study. Stroke. 1997;28:2222–2229
  32. Fisher CM. Lacunar infarcts: a review. Cerebrovasc Dis. 1991;1:311–320
  33. Weisberg LA. Diagnostic classification of stroke, especially lacunes. Stroke. 1998;19(9):1071–1073
  34. Bamford JM, Warlow CP. Evolution and testing of the lacunar hypothesis. Stroke. 1988;19(9):1074–1081
  35. Horowitz DR, Tuhrim S, Weinberger JM, Rudolph SH. Mechanism in lacunar infarction. Stroke. 1992;23:325–327
  36. Dozono K, Ishii N, Nishihara Y, Horie A. An autopsy study of the incidence of lacunes in relation to age, hypertension and arteriosclerosis. Stroke. 1991;22:993–996
  37. Melo TP, Bogousslavsky J, van Melle G, Regli F. Pure motor stroke: a reappraisal. Neurology. 1992;42:789–795
  38. Kim JS. Pure sensory stroke: clinical-radiological correlates in 21 cases. Stroke. 1992;23:983–987
  39. Moulin T. Ataxic hemiparesis: 100 vascular cases. Cerebrovasc Dis. 1992;2:199;[Abstract]
  40. Glass JD, Levey AI, Rothstein JD. The dysarthria-clumsy hand syndrome. A distinct clinical entity related to pontine infarction. Ann Neurol. 1990;27:487–494
  41. Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke. 2002;33:1536–1540
  42. Gorter JW for the Stroke Prevention in Reversible Ischemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Neurology. 1999;53:1319–1327
  43. Smith EE, Rosand J, Knudsen BA, Hyleck EM, Greenberg SM. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke: the Cardiovascular Health Study. Neurology. 2002;59:193–197
  44. Kuo HK, Lipsitz LA. Cerebral white matter changes and geriatric syndromes: is there a link?. J Gerontol A Biol Sci Med Sci. 2004;59(8):818–826
  45. Cadelo M, Inzitari D, Pracucci G, Mascalchi M. Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis. 1991;1:345–351
  46. Junqué C, Pujol J, Vendrell P, et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol. 1990;47:151–156
  47. Coffey CE, Figiel GS, Djang WT, Weiner RD. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry. 1990;147:187–189
  48. Breitner JCS, Husain MM, Figiel GS, Krishnan KRR, Boyko OB. Cerebral white matter disease in late-onset paranoid psychosis. Biol Psychiatry. 1990;28:266–274
  49. Dupont RM, Jernigan TL, Butters N, et al. Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Arch Gen Psychiatry. 1990;47:55–59
  50. Swayze VW, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WTC. Structural brain abnormalities in bipolar affective disorder. Arch Gen Psychiatry. 1990;47:1054–1059
  51. Gass A, Ay H, Szabo K, Koroshetz WJ. Diffusion-weighted MRI for the “small stuff”: the details of acute cerebral ischaemia. Lancet Neurol. 2004;3(1):39–45
  52. Lee SH, Kwon SJ, Kim KS, Yoon BW, Roh JK. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol. 2004;251(10):1183–1189
  53. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke. 1995;26(7):1293–1301
  54. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652–659
  55. Shimode K, Kobayashi S, Imaoka K, Umegae N, Nagai A. Leukoencephalopathy-related cerebral amyloid angiopathy with cystatin C deposition. Stroke. 1996;27(8):1417–1419
  56. Caulo M, Tampieri D, Brassard R, Christine Guiot M, Melanson D. Cerebral amyloid angiopathy presenting as nonhemorrhagic diffuse encephalopathy: neuropathologic and neuroradiologic manifestations in one case. Am J Neuroradiol. 2001;22(6):1072–1076
  57. Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993;3(3):256–259
  58. LaPoint SF, Patel U, Rubio A. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Adv Anat Pathol. 2000;7(5):307–321
  59. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke. 1992;23:1434–1438
  60. Inzitari D, Di Carlo A, Mascalchi M, Pracucci G, Amaducci L. The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol. 1995;52:687–691
  61. Yamauchi H, Fukuda H, Oyanagi C. Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis. J Neurol Neurosurg Psychiatry. 2002;72:576–582
  62. Giele JL, Witkamp TD, Mali WP, van der Graaf Y SMART Study Group. Silent brain infarcts in patients with manifest vascular disease. Stroke. 2004;35(March (3)):742–746
  63. Lexa FJ, Trojanawski JQ, Braffman BH. The aging brain and neurodegenerative disease. In:  Atlas SW editors. Magnetic resonance imaging of the brain and spine. 2nd ed.. Philadelphia, PA: Lippincott-Raven; 1996;p. 803–870
  64. Song CJ, Kim JH, Kier EL, Bronen RA. MR imaging and histologic features of subinsular bright spots on T2-weighted MR images: Virchow-Robin spaces of the extreme capsule and insular cortex. Radiology. 2000;214:671–677
  65. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(May (19)):1450–1460
  66. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Hypertension. 1998;31:1223–1229
  67. Qureshi AI, Suri MAK, Safdar K, Ottenlips JR, Janssen RS, Frankel MR. Intracerebral hemorrhage in blacks: risk factors, subtypes, and outcome. Stroke. 1997;28:961–964
  68. Massaro AR, Sacco LR, Mohr JP, Foulkes MA, Tatemichi TK, Price TR. Clinical discriminators of lobar and deep hemorrhage: The Stroke Data Bank. Neurology. 1991;41:1881–1885
  69. Heiskanen O. Treatment of spontaneous intracerebral and intracerebellar hemorrhages. Stroke. 1993;24(Suppl I):I94–I95
  70. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patient with supra-tentorial intracerebral hemorrhage. Neurology. 1994;44:1379–1384
  71. Kase CS, Mohr JP, Caplan LR. Intracerebral hemorrhage. In:  Barnett HJM,  Mohr JP,  Stein BM,  Yatsu FM editor. Stroke: pathophysiology, diagnosis, and management. 2nd ed.. New York: Churchill Livingston; 1992;p. 561–616
  72. Wakai S, Kumakura N, Nagai M. Lobar intracerebral hemorrhage. A clinical, radiographic and pathological study of 29 consecutive operated cases with negative angiography. J Neurosurg. 1992;76:231–238
  73. Challa VR, Moody DM, Bell MA. The Charcot-Bouchard aneurysms controversy: impact of a new histologic technique. J Neuropathol Exp Neurol. 1992;51:264–271
  74. Spangler KM, Challa VR, Moody , Bell MA. Arteriolar tortuosity of the white matter in aging and hypertension. A microradiographic study. J Neuropathol Exp Neurol. 1994;53:22–26
  75. Kreel L, Kay R, Woo J, Wong HY, Nicholls MG. The radiological (CT) and clinical sequelae of primary intracerebral hemorrhage. Br J Radiol. 1991;64:1096–1100
  76. McCarron MO, Nicoll JA. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol. 2004;3(8):484–492
  77. Nabavi DG, Csiba L, Ringelstein EB. Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology. 2005;64(7):1233–1237
  78. Dickinson CJ. Why are strokes related to hypertension? Classic studies and hypotheses revisited. J Hypertens. 2001;19:1515–1521
  79. Faraci FM, Baumbach GL, Heistad DD. Cerebral circulation: humoral regulation and effects of chronic hypertension. J Am Soc Nephrol. 1990;1:53–57
  80. de la Torre JC. Hemodynamics of deformed microvessels in Alzheimer's disease brain. Ann NY Acad Sci. 1997;826:75–91
  81. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5:347–360
  82. Escobales N, Crespo MJ. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol. 2005;3:231–246
  83. Faraci FM. Oxidative stress: the curse that underlies cerebral vascular dysfunction?. Stroke. 2005;36:186–188
  84. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 2003;61:1179–1184
  85. Fratiglioni L, De Ronchi D, Agùero-Torres H. World-wide prevalence and incidence of dementia. Drugs Aging. 1999;15:365–375
  86. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223
  87. Fratiglioni L, Launer L, Andersen K. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology. 2000;54(Suppl 5):S10–S15
  88. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev. 2002;1:61–77
  89. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol. 2004;3:184–190
  90. Launer LJ, Masaki K, Petrovich H, Foley D, Havlik RJ. The association between blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA. 1995;274:1846–1851
  91. Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: Analysis of published clinical data. J Neurol Sci. 2002;203/204:147–151
  92. Franklin SS, Gustin IVW, Wong ND. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96:308–315
  93. Bots ML, Witteman JCM, Hofman A, de Jong PT, Grobbee DE. Low diastolic blood pressure and atherosclerosis in elderly subjects: the Rotterdam Study. Arch Intern Med. 1996;156:843–848
  94. Suter O-C, Sunthorn T, Kraftisik R. Cerebral hypoperfusion generates cortical watershed microinfasrcts in Alzheimer disease. Stroke. 2002;33:1986–1992
  95. Vagnucci AH, Li WW. Alzheimer's disease and angiogenesis. Lancet. 2003;361:605–608
  96. Kalback W, Esh C, Castano EM. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res. 2004;26:525–539
  97. van Dijk EJ, Breteler MM, Schmidt R. The association between blood pressure, hypertension, and cerebral white matter lesions: the Cardiovascular Determinants of Dementia Study. Hypertension. 2004;44:625–630
  98. Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of leukoaraiosis and cognition. Stroke. 2007;38(9):2619–2625
  99. Chui H, Victiroff J, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centres. Neurology. 1992;42:473–480
  100. Roman G, Tatemichi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International workshop. Neurology. 1993;43:250–260
  101. Gunning-Dixon F, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology. 2000;14:224–232
  102. Hachinski V, Iadecola C, Petersen R, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220–2241
  103. Desmond D. Cognition and white matter lesions. Cerebrovasc Dis. 2002;13(Suppl 2):53–57
  104. Parneti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs. 1997;53:752–768
  105. Mason RP, Leeds PR, Jacob RF. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J Neurochem. 1999;72:1448–1456
  106. Farkas E, De Jong GI, Apro E. Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain. Neurobiol Aging. 2001;22:299–309
  107. Morich FJ, Bieber F, Lewis JM. Nimodipine in the treatment of probable Alzheimer's disease: result of two multicentre trials. Clin Drug Invest. 1996;11:185–195
  108. Amenta F, Strocchi P, Sabbatini M. Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine. J Hypertens. 1996;14(Suppl 3):S29–S36
  109. Schrader J, et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Principal Results of a Prospective Randomized Controlled Study (MOSES). Stroke. 2005;36:1218–1226
  110. Fournier A, Messerli F, Achard J, Fernandez L. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomised clinical trials. J Am Coll Cardiol. 2004;43:1343–1347
  111. Iadecola C, Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke. 2004;35:348–350
  112. Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothalium: diverse signals and effects. Hypertension. 2005;45:163–169
  113. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes?. J Hypertens. 2005;23:463–473
  114. Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005;45:712–719
  115. Applegate WB, Pressels S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioural variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med. 1994;154:2154–2160
  116. Prince M, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. Br Med J. 1996;312:801–805
  117. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:2046–2052
  118. Forette F, Seux ML, Staessen JA, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Systolic Hypertension in Europe Investigators. Arch Intern Med. 2002;162:2046–2052
  119. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069–1075
  120. Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875–886
  121. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(May (19)):1450–1460

PII: S0021-9150(08)00752-1

doi: 10.1016/j.atherosclerosis.2008.10.028

Atherosclerosis
Volume 205, Issue 2 , Pages 331-341 , August 2009

Article Tools

* Image Usage & Resolution